Altered metabolism of lipids is currently considered a hallmark characteristic of many
malignancies, including colorectal cancer (CRC). Lipids are a large group of metabolites …

Colorectal cancer (CRC) is one of the most common aggressive carcinoma types worldwide,
characterized by unfavorable curative effect and poor prognosis. Epidemiological data re …

Accumulating evidence has reported that the gut microbiota could play important roles in the
occurrence and progression of colorectal cancer. The nondigestible plant polysaccharides …

Overweight, obesity, and metabolic syndrome (MetS) have become epidemic conditions
affecting 39%, 13%, and 20% of the population respectively. The aim of this article is to …

Population screening and endoscopic surveillance are used widely to prevent the
development of and death from colorectal cancer (CRC). However, CRC remains a major …

CRC is the third most commonly diagnosed malignancy and the fourth leading cause of
cancer-related death in the world. With advances in treatment, colorectal cancer is being …

With the exception of renal cell carcinoma, studies assessing the association between
hypertension and other cancers are inconsistent. We conducted a meta-analysis to assess …

Background & Aims The increasing prevalence of obesity at younger ages is concurrent with
an increased earlier-onset colorectal cancer (CRC)(before age 50 years) incidence …

Metabolic syndrome (MS) is characterized by a group of metabolic disturbances which lead
to an enhanced risk of cardiovascular diseases and type 2 diabetes mellitus. MS constitutes …

The peroxisome proliferator-activated receptors, PPARα, PPARβ, and PPARγ, are a family of
transcription factors activated by a diversity of molecules including fatty acids and fatty acid …